Coronary Artery Aneurysm after Second-Generation Drug-Eluting Stent Implantation

We evaluated the incidence, predictors, and prognosis of coronary artery aneurysm (CAA) after second-generation drug-eluting stent (DES) implantation. A total of 976 consecutive patients (1245 lesions) who underwent follow-up angiography after second-generation DES implantation were analyzed. Incide...

Full description

Saved in:
Bibliographic Details
Published inYonsei medical journal Vol. 60; no. 9; pp. 824 - 831
Main Authors Hong, Sung-Jin, Kim, Hyoeun, Ahn, Chul-Min, Kim, Jung-Sun, Kim, Byeong-Keuk, Ko, Young-Guk, Hong, Bum-Kee, Choi, Donghoon, Jang, Yangsoo, Hong, Myeong-Ki
Format Journal Article
LanguageEnglish
Published Korea (South) Yonsei University College of Medicine 01.09.2019
연세대학교의과대학
Subjects
Online AccessGet full text
ISSN0513-5796
1976-2437
1976-2437
DOI10.3349/ymj.2019.60.9.824

Cover

Loading…
Abstract We evaluated the incidence, predictors, and prognosis of coronary artery aneurysm (CAA) after second-generation drug-eluting stent (DES) implantation. A total of 976 consecutive patients (1245 lesions) who underwent follow-up angiography after second-generation DES implantation were analyzed. Incidence and predictors of CAA were assessed, and clinical prognosis was compared with 34 cases of CAA after first-generation DES implantation using previous CAA registry data. All 10 cases of CAA (0.80% per lesion) in 10 patients (1.02% per patient) were detected at follow up. Compared to lesions without CAA, those with CAA had greater involvement of the proximal segment (90% vs. 51%, =0.014), a higher proportion of pre-intervention, a Thrombolysis in Myocardial Infarction score of 0 or 1 flow (80% vs. 16%, <0.001), more chronic total occlusions (40% vs. 10%, <0.001), and longer implanted stents (41.9±23.2 mm vs. 28.8±14.8 mm, =0.006). As for CAA morphology, instances of CAA after second-generation DES were predominantly the single fusiform type (90%), whereas instances of CAA after first-generation DES were multiple saccular (47%) and single saccular (35%) types ( <0.001). Myocardial infarction with stent thrombosis occurred in 5 patients with CAA after first-generation DES (15%), and no adverse events were observed in patients with CAA after second-generation DES over a median follow-up duration of 4.3 years ( =0.047, log-rank). Although CAAs after second-generation DES implantation were detected at a similar incidence to that for CAAs after first-generation DES implantation, second-generation DES-related CAAs had different morphologies and more benign clinical outcomes versus first-generation DES-related CAAs.
AbstractList We evaluated the incidence, predictors, and prognosis of coronary artery aneurysm (CAA) after second-generation drug-eluting stent (DES) implantation.PURPOSEWe evaluated the incidence, predictors, and prognosis of coronary artery aneurysm (CAA) after second-generation drug-eluting stent (DES) implantation.A total of 976 consecutive patients (1245 lesions) who underwent follow-up angiography after second-generation DES implantation were analyzed. Incidence and predictors of CAA were assessed, and clinical prognosis was compared with 34 cases of CAA after first-generation DES implantation using previous CAA registry data.MATERIALS AND METHODSA total of 976 consecutive patients (1245 lesions) who underwent follow-up angiography after second-generation DES implantation were analyzed. Incidence and predictors of CAA were assessed, and clinical prognosis was compared with 34 cases of CAA after first-generation DES implantation using previous CAA registry data.All 10 cases of CAA (0.80% per lesion) in 10 patients (1.02% per patient) were detected at follow up. Compared to lesions without CAA, those with CAA had greater involvement of the proximal segment (90% vs. 51%, p=0.014), a higher proportion of pre-intervention, a Thrombolysis in Myocardial Infarction score of 0 or 1 flow (80% vs. 16%, p<0.001), more chronic total occlusions (40% vs. 10%, p<0.001), and longer implanted stents (41.9±23.2 mm vs. 28.8±14.8 mm, p=0.006). As for CAA morphology, instances of CAA after second-generation DES were predominantly the single fusiform type (90%), whereas instances of CAA after first-generation DES were multiple saccular (47%) and single saccular (35%) types (p<0.001). Myocardial infarction with stent thrombosis occurred in 5 patients with CAA after first-generation DES (15%), and no adverse events were observed in patients with CAA after second-generation DES over a median follow-up duration of 4.3 years (p=0.047, log-rank).RESULTSAll 10 cases of CAA (0.80% per lesion) in 10 patients (1.02% per patient) were detected at follow up. Compared to lesions without CAA, those with CAA had greater involvement of the proximal segment (90% vs. 51%, p=0.014), a higher proportion of pre-intervention, a Thrombolysis in Myocardial Infarction score of 0 or 1 flow (80% vs. 16%, p<0.001), more chronic total occlusions (40% vs. 10%, p<0.001), and longer implanted stents (41.9±23.2 mm vs. 28.8±14.8 mm, p=0.006). As for CAA morphology, instances of CAA after second-generation DES were predominantly the single fusiform type (90%), whereas instances of CAA after first-generation DES were multiple saccular (47%) and single saccular (35%) types (p<0.001). Myocardial infarction with stent thrombosis occurred in 5 patients with CAA after first-generation DES (15%), and no adverse events were observed in patients with CAA after second-generation DES over a median follow-up duration of 4.3 years (p=0.047, log-rank).Although CAAs after second-generation DES implantation were detected at a similar incidence to that for CAAs after first-generation DES implantation, second-generation DES-related CAAs had different morphologies and more benign clinical outcomes versus first-generation DES-related CAAs.CONCLUSIONAlthough CAAs after second-generation DES implantation were detected at a similar incidence to that for CAAs after first-generation DES implantation, second-generation DES-related CAAs had different morphologies and more benign clinical outcomes versus first-generation DES-related CAAs.
Purpose: We evaluated the incidence, predictors, and prognosis of coronary artery aneurysm (CAA) after second-generationdrug-eluting stent (DES) implantation. Materials and Methods: A total of 976 consecutive patients (1245 lesions) who underwent follow-up angiography after secondgenerationDES implantation were analyzed. Incidence and predictors of CAA were assessed, and clinical prognosis was comparedwith 34 cases of CAA after first-generation DES implantation using previous CAA registry data. Results: All 10 cases of CAA (0.80% per lesion) in 10 patients (1.02% per patient) were detected at follow up. Compared to lesionswithout CAA, those with CAA had greater involvement of the proximal segment (90% vs. 51%, p=0.014), a higher proportion ofpre-intervention, a Thrombolysis in Myocardial Infarction score of 0 or 1 flow (80% vs. 16%, p<0.001), more chronic total occlusions(40% vs. 10%, p<0.001), and longer implanted stents (41.9±23.2 mm vs. 28.8±14.8 mm, p=0.006). As for CAA morphology,instances of CAA after second-generation DES were predominantly the single fusiform type (90%), whereas instances of CAA afterfirst-generation DES were multiple saccular (47%) and single saccular (35%) types (p<0.001). Myocardial infarction with stentthrombosis occurred in 5 patients with CAA after first-generation DES (15%), and no adverse events were observed in patientswith CAA after second-generation DES over a median follow-up duration of 4.3 years (p=0.047, log-rank). Conclusion: Although CAAs after second-generation DES implantation were detected at a similar incidence to that for CAAs afterfirst-generation DES implantation, second-generation DES-related CAAs had different morphologies and more benign clinicaloutcomes versus first-generation DES-related CAAs. KCI Citation Count: 0
We evaluated the incidence, predictors, and prognosis of coronary artery aneurysm (CAA) after second-generation drug-eluting stent (DES) implantation. A total of 976 consecutive patients (1245 lesions) who underwent follow-up angiography after second-generation DES implantation were analyzed. Incidence and predictors of CAA were assessed, and clinical prognosis was compared with 34 cases of CAA after first-generation DES implantation using previous CAA registry data. All 10 cases of CAA (0.80% per lesion) in 10 patients (1.02% per patient) were detected at follow up. Compared to lesions without CAA, those with CAA had greater involvement of the proximal segment (90% vs. 51%, =0.014), a higher proportion of pre-intervention, a Thrombolysis in Myocardial Infarction score of 0 or 1 flow (80% vs. 16%, <0.001), more chronic total occlusions (40% vs. 10%, <0.001), and longer implanted stents (41.9±23.2 mm vs. 28.8±14.8 mm, =0.006). As for CAA morphology, instances of CAA after second-generation DES were predominantly the single fusiform type (90%), whereas instances of CAA after first-generation DES were multiple saccular (47%) and single saccular (35%) types ( <0.001). Myocardial infarction with stent thrombosis occurred in 5 patients with CAA after first-generation DES (15%), and no adverse events were observed in patients with CAA after second-generation DES over a median follow-up duration of 4.3 years ( =0.047, log-rank). Although CAAs after second-generation DES implantation were detected at a similar incidence to that for CAAs after first-generation DES implantation, second-generation DES-related CAAs had different morphologies and more benign clinical outcomes versus first-generation DES-related CAAs.
Author Kim, Byeong-Keuk
Choi, Donghoon
Ko, Young-Guk
Kim, Jung-Sun
Hong, Sung-Jin
Hong, Bum-Kee
Jang, Yangsoo
Kim, Hyoeun
Ahn, Chul-Min
Hong, Myeong-Ki
AuthorAffiliation 3 Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Korea
1 Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Korea
2 Division of Cardiology, Department of Internal Medicine, Gangnam Severance Hospital, Seoul, Korea
AuthorAffiliation_xml – name: 2 Division of Cardiology, Department of Internal Medicine, Gangnam Severance Hospital, Seoul, Korea
– name: 3 Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Korea
– name: 1 Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Korea
Author_xml – sequence: 1
  givenname: Sung-Jin
  orcidid: 0000-0003-4893-039X
  surname: Hong
  fullname: Hong, Sung-Jin
  organization: Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Korea
– sequence: 2
  givenname: Hyoeun
  orcidid: 0000-0002-7334-9700
  surname: Kim
  fullname: Kim, Hyoeun
  organization: Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Korea
– sequence: 3
  givenname: Chul-Min
  orcidid: 0000-0002-7071-4370
  surname: Ahn
  fullname: Ahn, Chul-Min
  organization: Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Korea
– sequence: 4
  givenname: Jung-Sun
  orcidid: 0000-0003-2263-3274
  surname: Kim
  fullname: Kim, Jung-Sun
  organization: Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Korea
– sequence: 5
  givenname: Byeong-Keuk
  orcidid: 0000-0003-2493-066X
  surname: Kim
  fullname: Kim, Byeong-Keuk
  organization: Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Korea
– sequence: 6
  givenname: Young-Guk
  orcidid: 0000-0001-7748-5788
  surname: Ko
  fullname: Ko, Young-Guk
  organization: Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Korea
– sequence: 7
  givenname: Bum-Kee
  orcidid: 0000-0002-6456-0184
  surname: Hong
  fullname: Hong, Bum-Kee
  organization: Division of Cardiology, Department of Internal Medicine, Gangnam Severance Hospital, Seoul, Korea
– sequence: 8
  givenname: Donghoon
  orcidid: 0000-0002-2009-9760
  surname: Choi
  fullname: Choi, Donghoon
  organization: Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Korea., Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Korea
– sequence: 9
  givenname: Yangsoo
  orcidid: 0000-0002-2169-3112
  surname: Jang
  fullname: Jang, Yangsoo
  organization: Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Korea., Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Korea
– sequence: 10
  givenname: Myeong-Ki
  orcidid: 0000-0002-2090-2031
  surname: Hong
  fullname: Hong, Myeong-Ki
  organization: Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Korea., Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31433580$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002492473$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp1UU1P3DAQtSqqslB-QC9Vju0h6diOnfhSabVQWAkJVOBseZ3JNpDYWzuptP--3l1AbaWenqx5H555J-TIeYeEfKBQcF6qL9vhsWBAVSGhUEXNyjdkRlUlc1by6ojMQFCei0rJY3IS4yMAqyiwd-SY05JzUcOM3C588M6EbTYPI-7A4RS2cchMm97ZHVrvmvwSHQYzdt5l52Fa5xf9NHZund2N6MZsOWx648b9_D1525o-4tkznpKHbxf3i6v8-uZyuZhf5zZFjzltJAWjBAgUtGkp8FpWdoWsbW3V0FJZIaURKBtWIjCwWMJqBbWkKJE1lJ-SzwdfF1r9ZDvtTbfHtddPQc-_3y-1UJJVpUzcrwfuZloN2Nj052B6vQndkDbfK_-euO5H8vmlZQUlMJYMPj0bBP9zwjjqoYsW-7Q1-ilqxmpO02n5Luvjn1mvIS8nT4TqQLDBxxiw1bY7nC5Fd72moHfl6lSu3pWrJWilU7lJSf9Rvpj_X_Mb7qmoxw
CitedBy_id crossref_primary_10_1002_ccd_29193
crossref_primary_10_1016_j_ihjccr_2020_11_001
crossref_primary_10_1016_j_ihjcvr_2024_09_001
crossref_primary_10_2174_1573403X19666230331103508
crossref_primary_10_4103_jiae_jiae_69_23
crossref_primary_10_1097_MD_0000000000032839
crossref_primary_10_4070_kcj_2020_0198
crossref_primary_10_1007_s40278_019_70795_2
crossref_primary_10_1016_j_ijcha_2021_100793
Cites_doi 10.1016/j.jacc.2018.08.1038
10.1016/j.ahj.2010.07.013
10.1161/CIRCINTERVENTIONS.113.000945
10.1016/0735-1097(92)90439-T
10.1161/CIRCULATIONAHA.106.685313
10.1093/eurheartj/ehi571
10.1016/0735-1097(91)90685-3
10.1161/ATVBAHA.107.144220
10.1016/j.jacc.2009.01.069
10.1016/j.ijcard.2015.02.082
10.1002/ccd.27429
10.1161/01.RES.0000233379.92010.fd
10.1016/j.jcin.2007.10.004
10.1016/S0002-9149(97)00055-6
ContentType Journal Article
Copyright Copyright: Yonsei University College of Medicine 2019.
Copyright: Yonsei University College of Medicine 2019 2019 Yonsei University College of Medicine
Copyright_xml – notice: Copyright: Yonsei University College of Medicine 2019.
– notice: Copyright: Yonsei University College of Medicine 2019 2019 Yonsei University College of Medicine
DBID AAYXX
CITATION
NPM
7X8
5PM
ACYCR
DOI 10.3349/ymj.2019.60.9.824
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1976-2437
EndPage 831
ExternalDocumentID oai_kci_go_kr_ARTI_5962746
PMC6704022
31433580
10_3349_ymj_2019_60_9_824
Genre Journal Article
GrantInformation_xml – fundername: Ministry of Health and Welfare
  grantid: HI15C1277
– fundername: National Research Foundation of Korea
  grantid: 2015R1A2A2A01002731
– fundername: Ministry of Health and Welfare
  grantid: A085136
– fundername: Cardiovascular Research Center
– fundername: ;
  grantid: nos. A085136; HI15C1277
– fundername: ;
– fundername: ;
  grantid: 2015R1A2A2A01002731
GroupedDBID ---
.55
.GJ
123
29R
2WC
36B
5-W
53G
5RE
8JR
8XY
9ZL
AAYXX
ACYCR
ADBBV
ADRAZ
AEGXH
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
CS3
DIK
DU5
E3Z
EBD
EF.
EMB
EMOBN
F5P
GROUPED_DOAJ
GX1
HYE
KQ8
L7B
M48
MK0
O5R
O5S
OK1
OVT
P2P
PGMZT
RNS
RPM
SV3
TR2
X7M
XSB
ZGI
ZXP
NPM
7X8
5PM
M~E
ID FETCH-LOGICAL-c433t-1d610a9505e51df103867cbe2ffc7d149c566a5e6d24e020ce40bb0861e6e2d13
IEDL.DBID M48
ISSN 0513-5796
1976-2437
IngestDate Tue Nov 21 21:47:11 EST 2023
Thu Aug 21 14:08:40 EDT 2025
Fri Jul 11 15:13:41 EDT 2025
Mon Jul 21 06:02:44 EDT 2025
Thu Apr 24 22:57:49 EDT 2025
Tue Jul 01 04:03:16 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Coronary artery disease
percutaneous coronary intervention
drug-eluting stent
Language English
License Copyright: Yonsei University College of Medicine 2019.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c433t-1d610a9505e51df103867cbe2ffc7d149c566a5e6d24e020ce40bb0861e6e2d13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Sung-Jin Hong and Hyoeun Kim contributed equally to this work.
https://www.eymj.org/DOIx.php?id=10.3349/ymj.2019.60.9.824
ORCID 0000-0002-2090-2031
0000-0003-2263-3274
0000-0003-4893-039X
0000-0003-2493-066X
0000-0002-6456-0184
0000-0002-7071-4370
0000-0002-2009-9760
0000-0002-2169-3112
0000-0002-7334-9700
0000-0001-7748-5788
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3349/ymj.2019.60.9.824
PMID 31433580
PQID 2283110236
PQPubID 23479
PageCount 8
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_5962746
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6704022
proquest_miscellaneous_2283110236
pubmed_primary_31433580
crossref_citationtrail_10_3349_ymj_2019_60_9_824
crossref_primary_10_3349_ymj_2019_60_9_824
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-09-01
PublicationDateYYYYMMDD 2019-09-01
PublicationDate_xml – month: 09
  year: 2019
  text: 2019-09-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Yonsei medical journal
PublicationTitleAlternate Yonsei Med J
PublicationYear 2019
Publisher Yonsei University College of Medicine
연세대학교의과대학
Publisher_xml – name: Yonsei University College of Medicine
– name: 연세대학교의과대학
References Kadakia (10.3349/ymj.2019.60.9.824_ref6) 2014; 7
Thygesen (10.3349/ymj.2019.60.9.824_ref9) 2018; 72
Alfonso (10.3349/ymj.2019.60.9.824_ref1) 2009; 53
Zbinden (10.3349/ymj.2019.60.9.824_ref5) 2008; 20
Rab (10.3349/ymj.2019.60.9.824_ref12) 1991; 18
Finn (10.3349/ymj.2019.60.9.824_ref13) 2007; 27
Hofma (10.3349/ymj.2019.60.9.824_ref15) 2006; 27
Slota (10.3349/ymj.2019.60.9.824_ref10) 1997; 79
Bell (10.3349/ymj.2019.60.9.824_ref11) 1992; 20
Cutlip (10.3349/ymj.2019.60.9.824_ref8) 2007; 115
Joo (10.3349/ymj.2019.60.9.824_ref3) 2018; 92
Ahn (10.3349/ymj.2019.60.9.824_ref4) 2010; 160
Stähli (10.3349/ymj.2019.60.9.824_ref14) 2006; 99
Goldberg (10.3349/ymj.2019.60.9.824_ref7) 2015; 184
Aoki (10.3349/ymj.2019.60.9.824_ref2) 2008; 1
References_xml – volume: 72
  start-page: 2231
  year: 2018
  ident: 10.3349/ymj.2019.60.9.824_ref9
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2018.08.1038
– volume: 160
  start-page: 987
  year: 2010
  ident: 10.3349/ymj.2019.60.9.824_ref4
  publication-title: Am Heart J
  doi: 10.1016/j.ahj.2010.07.013
– volume: 7
  start-page: 266
  year: 2014
  ident: 10.3349/ymj.2019.60.9.824_ref6
  publication-title: Circ Cardiovasc Interv
  doi: 10.1161/CIRCINTERVENTIONS.113.000945
– volume: 20
  start-page: 1474
  year: 1992
  ident: 10.3349/ymj.2019.60.9.824_ref11
  publication-title: J Am Coll Cardiol
  doi: 10.1016/0735-1097(92)90439-T
– volume: 20
  start-page: E174
  year: 2008
  ident: 10.3349/ymj.2019.60.9.824_ref5
  publication-title: J Invasive Cardiol
– volume: 115
  start-page: 2344
  year: 2007
  ident: 10.3349/ymj.2019.60.9.824_ref8
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.106.685313
– volume: 27
  start-page: 166
  year: 2006
  ident: 10.3349/ymj.2019.60.9.824_ref15
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehi571
– volume: 18
  start-page: 1524
  year: 1991
  ident: 10.3349/ymj.2019.60.9.824_ref12
  publication-title: J Am Coll Cardiol
  doi: 10.1016/0735-1097(91)90685-3
– volume: 27
  start-page: 1500
  year: 2007
  ident: 10.3349/ymj.2019.60.9.824_ref13
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.107.144220
– volume: 53
  start-page: 2053
  year: 2009
  ident: 10.3349/ymj.2019.60.9.824_ref1
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2009.01.069
– volume: 184
  start-page: 487
  year: 2015
  ident: 10.3349/ymj.2019.60.9.824_ref7
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2015.02.082
– volume: 92
  start-page: E235
  year: 2018
  ident: 10.3349/ymj.2019.60.9.824_ref3
  publication-title: Catheter Cardiovasc Interv
  doi: 10.1002/ccd.27429
– volume: 99
  start-page: 149
  year: 2006
  ident: 10.3349/ymj.2019.60.9.824_ref14
  publication-title: Circ Res
  doi: 10.1161/01.RES.0000233379.92010.fd
– volume: 1
  start-page: 14
  year: 2008
  ident: 10.3349/ymj.2019.60.9.824_ref2
  publication-title: JACC Cardiovasc Interv
  doi: 10.1016/j.jcin.2007.10.004
– volume: 79
  start-page: 1104
  year: 1997
  ident: 10.3349/ymj.2019.60.9.824_ref10
  publication-title: Am J Cardiol
  doi: 10.1016/S0002-9149(97)00055-6
SSID ssj0027102
Score 2.2560582
Snippet We evaluated the incidence, predictors, and prognosis of coronary artery aneurysm (CAA) after second-generation drug-eluting stent (DES) implantation. A total...
We evaluated the incidence, predictors, and prognosis of coronary artery aneurysm (CAA) after second-generation drug-eluting stent (DES) implantation.PURPOSEWe...
Purpose: We evaluated the incidence, predictors, and prognosis of coronary artery aneurysm (CAA) after second-generationdrug-eluting stent (DES) implantation....
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 824
SubjectTerms Original
의학일반
Title Coronary Artery Aneurysm after Second-Generation Drug-Eluting Stent Implantation
URI https://www.ncbi.nlm.nih.gov/pubmed/31433580
https://www.proquest.com/docview/2283110236
https://pubmed.ncbi.nlm.nih.gov/PMC6704022
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002492473
Volume 60
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Yonsei Medical Journal, 2019, 60(9), , pp.824-831
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LT9tAEB4RkKpeqgJ9hELkVpwqberHeh0fKoR4iFYKQqJRua325ZQCDnUSqfn3nfE6gaCo4uSDx155ZtbzjWf8DcB-bosiKlyGFuCGcc41bimuWJxppXo2y3Rdiumfi7MB_36VXq3BfLxVo8DxytSO5kkNqtvu3z-zA9zwXynjTHj-ZXb3m3q08q4Iu2j5mLdgAwOTICfv895D_hX5FkSMwIx4-HyRc_UtlsJUq6yKVQj0aSPlo8h0-hpeNZAyOPQ-sAlrrtyCF_2maL4NF0fEUqCqGYk4OhCJ5Wx8F9QDwoNLyokt8wTUZKfguJoO2Qn5ZDkMLhFVTwJiEVb-N6XyDQxOT34cnbFmkAIzPEkmLLIIklSOYMelkS2IE11kRru4KExmMUcyCOpU6oSNuUP8aBwPtcZkJ3LCxTZK3sJ6OSrdewisVmmiuOkJbTBZShXx3RVEQ5-Gic2jNoRzvUnTsIzTsItbidkGqVqiqiWpWopQ5hJV3YbPi0vuPcXG_4Q_oTHkjbmWRIxNx-FI3lQS4f836UcJiTZ8nNtK4m6hEogq3Wg6lkT2ExFbBcq887ZbrJkgdKSicBuyJasuBGjB5TPl9a-akVtk-C6M451nrPsBXtID-Ta1XVifVFO3h7hmojvQStnPTv1VoFN77j8Qn_bj
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Coronary+Artery+Aneurysm+after+Second-Generation+Drug-Eluting+Stent+Implantation&rft.jtitle=Yonsei+medical+journal&rft.au=Hong%2C+Sung+Jin&rft.au=Kim%2C+Hyoeun&rft.au=Ahn%2C+Chul+Min&rft.au=Kim%2C+Jung+Sun&rft.date=2019-09-01&rft.issn=1976-2437&rft.eissn=1976-2437&rft.volume=60&rft.issue=9&rft.spage=824&rft_id=info:doi/10.3349%2Fymj.2019.60.9.824&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0513-5796&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0513-5796&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0513-5796&client=summon